RNA Therapeutics Beyond Vaccines
RNA therapeutics are currently enjoying the center stage spotlight in the drug development sector, thanks to the quick turnaround time of COVID-19 vaccines. Scientists have steadily worked on improving the stability, durability and delivery of mRNA and siRNA for decades and RNA therapeutics are primed to be at the frontline of biologics to treat cancer, infectious diseases and rare genetic disorders. At the 25th annual meeting of the American Society for Gene and Cell Therapy (ASGCT), researchers from industry and academia shared their experience of developing RNA drugs for various applications and improving their efficacy, targeting and specificity.
It's free! Log in now to read
LATEST
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06